Commercial Space Company Risk / Opportunity Ranking

Thesis: No positive investment thesis can be supported because the reviewed sources contain no direct positive evidence for Camphouse after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says only a generic roundup mention was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No positive investment thesis can be supported because the reviewed sources contain no direct positive evidence for Capsa AI after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says only a generic funding roundup was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No positive investment thesis can be supported because the reviewed sources contain no direct positive evidence for CardNexus after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says the reviewed sources does not provide direct company-specific evidence and references: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No positive investment thesis can be supported because the reviewed sources contain no direct positive evidence for CeQur after the 90-day recent evidence window.

Why now: There is no current catalyst in the local reviewed sources. Coverage debug shows 1 article considered but 0 articles after recent evidence window and 0 evidence available after dedupe; recency-based judgment is therefore unavailable.

Caveats: Phase-2 membership rationale says only a generic funding roundup was provided, tied to: but no is supplied in the reviewed sources so it cannot be cited as factual support. Evidence recent evidence review shows cutoff date March 29, 2026 with 0 kept rows and 0 undated rows kept.

Thesis: No reviewed sources-supported positive thesis is available. The reviewed sources explicitly says the summaries do not clearly connect CITIC Group to a qualifying space business.

Why now: There is no current catalyst. Despite 4,475 article IDs considered, the reviewed sources reports zero article IDs after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase2 rationale references article IDs: and: as context, but no were provided in the reviewed sources. Very large raw mention universe does not imply conviction or thesis attractiveness. Possible name/alias ambiguity is unresolved by the reviewed sources.

Thesis: No positive thesis is supported. The reviewed sources rationale says COMSAT appears only in the context of Intuitive Machines acquiring Goonhilly Earth Station/COMSAT, which is indirect and not sufficient for a company-specific opportunity view.

Why now: No 90-day article summaries or evidence were available for COMSAT in these reviewed sources, so there is no supported timing catalyst.

Caveats: Relations/context-only style mention should not be used as counterparty propagation evidence. Phase2 rationale references article ids: and: but no or summaries are provided in the reviewed sources. No direct evidence were available after recent evidence window.

Thesis: No positive thesis is supportable from retained reviewed sources evidence. The phase-2 rationale says EaglePicher is a key player in space batteries and that its systems were on NASA CLPS lunar lander missions, but no retained direct positive evidence or article summaries are available here.

Why now: No current catalyst is evidenced in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase-2 rationale references article, but the reviewed sources does not include the article summary or retained evidence. Supplier relevance to the space ecosystem does not by itself justify an opportunity score without current retained evidence. Recency is uncertain because the supporting substantive claims are not preserved in the recent evidence window evidence set.

Thesis: The reviewed sources only indicates service/testing relevance in a Sidus-related context, and it contains no retained direct positive evidence with inside the recent evidence window, so there is no supported opportunity thesis.

Why now: Why now is absent because only 2 articles were considered and none survived the 90-day filter; there is no current evidence basis for a 1 year+ directional call.

Caveats: Coverage is extremely sparse. The only described relation is context/service oriented and relations are context-only unless policy-gated. No post-cutoff evidence available.

Thesis: No positive thesis is supportable from retained reviewed sources evidence. The phase-2 rationale references IHI benefiting from ICEYE SAR satellites and planning multi-sensor integration, but no retained direct evidence or article summaries are present here.

Why now: There is no current why-now signal in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase-2 rationale references article: but the actual retained evidence is absent from these reviewed sources. The rationale itself frames IHI more as a beneficiary/customer than clearly as the core space operator, which weakens directional use even if the older article were available.

Thesis: No direct positive evidence is available, and the reviewed sources say the included summaries do not clearly establish what Island Green Capital is.

Why now: No timing-based catalyst is supported because no post-recent evidence window evidence were available.

Caveats: Phase2 rationale references article IDs: and: but no were provided in the reviewed sources. Reviewed evidence states summaries were about Molten Ventures and Isar Aerospace rather than clearly about Island Green Capital. Context-only mentions cannot support propagation.

Thesis: No positive thesis is supportable from retained reviewed sources evidence because there are no direct positive evidence and no articles retained after the 90-day recent evidence window.

Why now: There is no current why-now signal in the reviewed evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after dedupe/recent evidence window.

Caveats: Phase-2 rationale references article: but that article content is not provided here and no retained evidence remain after recent evidence window. Membership review status is not directional proof. Absence of evidence should not be interpreted as absence of business activity.

Thesis: No positive thesis is supportable from retained reviewed sources evidence. The phase-2 rationale describes air-launch and testing platform exposure, but no retained direct positive evidence or article summaries are provided here.

Why now: No current why-now signal is available in the retained evidence. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window despite substantial historical article count.

Caveats: Phase-2 rationale references articles: and: but their content is not included here. Historical mention density is not conviction. Public listing/ticker presence does not create a directional thesis without retained evidence.

Thesis: No positive thesis is supportable from retained reviewed sources evidence. The phase-2 rationale notes a letter of intent related to debris removal services, but no direct retained evidence row or article summary is provided in these reviewed sources.

Why now: No current why-now signal is available in the retained evidence. Coverage debug shows zero articles after recent evidence window and zero evidence after recent evidence window.

Caveats: Phase-2 rationale references article: but the underlying article details are not included here. A referenced letter of intent, without retained evidence details or timing, is insufficient for a 1 year+ directional ranking. Private-company status may limit visibility, but that is not itself a thesis.

Thesis: No supported positive thesis. The reviewed sources say SWISSto12 is only mentioned in passing in an article about SpaceLocker, which is provisional single-article context and not company-specific evidence, unavailable in reviewed sources).

Why now: There is no identifiable catalyst because the reviewed sources provide only a passing mention and no direct event or fact evidence.

Caveats: No current evidence is provided for. Support level is provisional single-article context only. No evidence available after recent evidence window.

Thesis: No positive thesis is supported. Veact appears only via a broad funding roundup and is not linked to a space-specific category in the reviewed sources.

Why now: No why-now catalyst is supported because the reviewed sources contain no post-recent evidence window evidence.

Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. A broad funding roundup is not enough to establish thesis direction. Coverage data shows articles after recent evidence window = 0.

Thesis: No direct positive evidence is available. The reviewed sources only says Volteum surfaced from a general funding roundup with no space-specific linkage.

Why now: No catalyst is supported in the reviewed sources due to zero post-recent evidence window evidence.

Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. Funding-roundup presence alone is not directional proof. Evidence strength remains minimal.

Thesis: No reviewed sources-supported positive thesis is available. Zaro is only listed in a general funding roundup with no direct linkage to a qualifying space thesis.

Why now: There is no current or durable catalyst supported by the reviewed sources because no evidence survived into the available post-recent evidence window set.

Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. General funding-roundup context is weaker than direct event or fact evidence. Coverage remains insufficient for a directional call.

Thesis: No positive thesis can be supported from the reviewed sources because there is no direct positive evidence available for Zone14 within the 90-day recent evidence window.

Why now: There is no current company-specific catalyst visible in the reviewed sources. Coverage debug shows zero articles after recent evidence window and zero evidence after recent evidence window for Zone14; the membership note says it appears only through a broad funding roundup and lacks company-specific evidence tied to the listed scope.

Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article Evidence recent evidence review shows 0 kept rows after the March 29, 2026 cutoff. Company appears only in review status with low membership confidence, which is not directional evidence.

Thesis: The same geopolitical context that implies imagery relevance also raises some reputational/regulatory uncertainty, but the reviewed sources does not provide direct negative evidence. Risk is slightly elevated only because the evidence context is indirect and sensitive rather than commercially validating.

Why now: No in-recent evidence window article summary or evidence row is available for MizarVision. The only timing cue is an uncited phase2 rationale referencing article id without.

Caveats: Evidence is indirect and not strongly company-specific according to the reviewed sources rationale. No citable article or summary is provided for the referenced article id. No evidence were available after recent evidence window.

Thesis: A slight risk score above the minimum is warranted because the phase-2 rationale references a lawsuit context involving Moog Space tied to article, but the reviewed sources provide no or retained details, so this cannot support a stronger negative thesis.

Why now: Why now is weak because the reviewed sources have no within the recent evidence window evidence; evidence recent evidence review kept_rows is 0 and coverage data articles after recent evidence window is 0.

Caveats: The lawsuit reference exists only in phase-2 rationale without or retained evidence detail, so it is too weak for a material risk call. No direct evidence arrays are populated. Score reflects limited unresolved risk context plus very sparse evidence.

Thesis: The concept appears early-stage from the membership rationale, and without retained post-recent evidence window evidence, development, technical, and funding-continuity risk dominate the current evidence picture.

Why now: There is no strong why-now signal because coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window; the cited support article is referenced only in membership rationale without a in the reviewed sources.

Caveats: No article is provided for membership support article, so the underlying factual statements cannot be elevated beyond low-confidence context. No direct positive or direct negative evidence are available after recent evidence window. Long-horizon potential exists, but current reviewed sources support is too thin for a stronger score.

Thesis: Risk is mostly uncertainty risk: the reviewed sources does not provide material adverse evidence, but it also lacks recent dated company-specific proof of traction, making the business outlook hard to assess.

Why now: Why now is weak because the only provided evidence is undated context from Space Index identifying Motiv as operating in in-orbit servicing; no recent dated milestone or contract is supplied.

Caveats: Evidence is undated and supporting article context only. Reviewed evidence membership rationale mentions acquisition by Rocket Lab and robotics products, but no citable evidence are included here for direct ranking use. No current source-cited catalyst was found in the reviewed sources.

Thesis: Risk is modestly elevated only because the reviewed sources frames Mynaric as a component supplier with classification ambiguity and no surviving fresh evidence; there is still no direct adverse evidence cited within the recent evidence window.

Why now: No within the recent evidence window retained evidence exists. The reviewed sources references and in the membership rationale, but no or retained evidence are provided here.

Caveats: No available direct evidence survived the 90-day recent evidence window. Acquisition/status claim appears only in membership rationale here and cannot be fully evaluated for timing without or timestamps.

Thesis: Ownership/status transition risk may matter because the reviewed sources describes Mynaric as acquired, but chronology, terms, and current status are not citable from the provided data, and no adverse evidence survive recent evidence window.

Why now: Potential relevance depends on the timing and implications of acquisition-related developments, yet the reviewed sources supplies no article summary, or surviving evidence row for article ids, or

Caveats: Acquisition-related statements are time-sensitive, but chronology cannot be verified from these reviewed sources because and timestamps are absent at the evidence level. No evidence remain after recent evidence window despite support references being listed. Slight score uplift reflects reviewed sources rationale about optical communications relevance only.

Thesis: Risk is chiefly lack of validated current progress: no retained evidence establishes recent funding, contracts, launches, or customer deployments.

Why now: There is no retained within the recent evidence window evidence in the reviewed sources, so there is no demonstrated current catalyst despite the company profile reference.

Caveats: Only a membership rationale is present; no recent evidence are retained. Score remains low due to evidence scarcity.

Thesis: No direct negative evidence is present, and NEC's risk score is kept relatively low because the reviewed sources does not show material adverse events; the main issue is simply lack of available current proof of execution or commercialization (: unavailable in reviewed sources).

Why now: Why now is medium rather than weak because an OTV development project can be durable over 1 year+, but evidentiary support in the reviewed sources are thin after recent evidence window.

Caveats: No current evidence is provided for No direct evidence remained after the recent evidence filter. Current milestone timing is unverified in the reviewed sources.

Thesis: Main risk is lack of validated current evidence: the reviewed sources only indicates counterparty/customer context and does not directly establish Neo Space Group's own operating role or near-term business momentum.

Why now: No validated near-term or durable timing signal is available in the available evidence. Recency is uncertain because zero after-recent evidence window evidence were available.

Caveats: Phase-2 rationale references, but no or summary is provided in the reviewed sources. Counterparty context should not be treated as propagated evidence for Neo Space Group's own thesis. Coverage debug shows zero evidence after recent evidence window.

Thesis: The reviewed sources provide no material adverse evidence; main risk is that the evidence base is thin and concentrated in a single cited article rather than multiple corroborated events.

Why now: The reviewed sources' membership rationale explicitly anchors current relevance to a Space Force contract and factory buildout tied to optical ground stations, citing article, though the article is not supplied in the reviewed sources.

Caveats: No representative article object or is included despite the cited article ID. Single-article support limits conviction.

Thesis: Current reviewed sources risk is uncertainty: no retained evidence confirms current orders, program milestones, or problems, leaving both upside and downside weakly evidenced.

Why now: There is no within the recent evidence window retained evidence to establish a fresh catalyst or changing business state.

Caveats: Only membership rationale is available; no quoted retained evidence are included. Low score reflects weak current evidence rather than a negative fundamental view.

Thesis: There is no direct negative evidence, but coverage is too thin to establish either durable upside or a specific adverse thesis.

Why now: There is no retained representative article or evidence row inside the current 90-day recent evidence window for Optera, so recency for the claimed funding support is uncertain in these reviewed sources.

Caveats: No retained evidence after recent evidence window. Phase-2 membership rationale is not enough for a high-conviction thesis on its own.

Thesis: The main risk is evidentiary and timing uncertainty: the most substantive operational claims are stale relative to the recent evidence window, while retained evidence is undated supporting article context rather than company-specific current contracts, customers, or financing.

Why now: Why now is only moderate because retained evidence after filtering consists of undated context from Space Index, not a dated current catalyst; the older company-site article from December 24, 2022 may indicate strategic readiness, but recency is weak

Caveats: Retained evidence is weak context and supporting article context, not direct event/fact evidence. The more detailed article is dated December 24, 2022 and was dropped by the 90-day recent evidence window; it should not be treated as current proof. The undated Space Index row is relevance context only and not recency proof.

Thesis: The main risk is execution and evidence scarcity: the reviewed sources show product claims but no dated commercial traction, contracts, or deployment proof within the recent evidence window. That is a real uncertainty, but not strong adverse evidence.

Why now: Why now is weak because the surviving evidence is undated company-context material rather than a fresh milestone. Recency-sensitive claims are uncertain

Caveats: Evidence kept after recent evidence window is undated and marked context, not recency proof. No direct positive event, contract, financing, or customer traction is available. Same-article repeated rows are not independent confirmation.

Thesis: The reviewed sources also states that Orbital does not clearly fit the named cohort categories, and no direct company-specific positive or negative evidence survive the recent evidence window in these reviewed sources. That makes the thesis speculative and category fit uncertain.

Why now: The only reason to rank it slightly above peers is the reviewed sources' description of funding plus a planned LEO satellite, which is at least directionally aligned with a 1 year+ horizon. But there is no retained dated evidence to verify recency, sequencing, or milestone timing.

Caveats: No are provided for the cited support articles in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. The positive view comes from phase2 rationale text rather than available direct event/facts.

Thesis: Execution risk is implicitly elevated because the rationale references a planned constellation and program participation rather than delivered operating results, but no direct adverse evidence is available.

Why now: The rationale references growth-oriented planned activity, which is relevant to a 1 year+ horizon, yet timing confidence is limited because coverage data shows no evidence after recent evidence window.

Caveats: Membership rationale references article IDs, and: but and article summaries are not provided in the reviewed sources. No direct positive_evidence or negative_evidence arrays are populated. Opportunity is based on stated plans, not validated conversion, contracts, or operating milestones inside the recent evidence window.

Thesis: Opportunity evidence is weakened by the fact that the key support is supporting article context rather than stronger structured company-event evidence, and the customer is undisclosed.

Why now: A representative article dated March 29, 2026 states Orion Space Solutions won initial contracts worth over $24 million to build more than 25 advanced payloads, with total potential value over $100 million and multi-year design, manufacturing, testing, and calibration work, which can matter over a 1 year+ horizon

Caveats: This is supporting article context and explicitly weaker than direct structured company-event evidence. The customer is undisclosed. Only one article is retained; same-article repetition is not independent confirmation.

Thesis: The main risk is evidence quality rather than identified business distress: the reviewed sources provide only supporting article context and no direct positive events or direct adverse rows, so thesis strength is limited and durability of traction beyond this deployment is uncertain.

Why now: A dated article with May 4, 2026 states that four satellites in the Hellenic Fire System launched and deployed on May 3, making Greece the first country with a sovereign operational wildfire-detection constellation; for a 1 year+ horizon, that kind of operational deployment can matter as a proof point for follow-on adoption if it persists

Caveats: The available evidence is weak context/supporting article context, not stronger company-specific events. Same article supplies the key claims, so this is not independent confirmation. No material adverse evidence is available, but absence of risk evidence is not proof of low risk.

Thesis: Risk is mostly lack of validation and scale uncertainty because there is only a one-article universe and zero available evidence after recent evidence window.

Why now: Why now is weak since the reviewed sources contain no direct post-recent evidence window evidence establishing current deal timing or mission progress.

Caveats: One-article universe with no citeable -bearing evidence available. Partnership mention in membership rationale cannot be strongly weighted without direct evidence.

Thesis: Risk is low-to-moderate only because evidence support is missing; the reviewed sources contain no direct adverse evidence, but it also does not provide ranking-grade proof of space-specific upside in the recent evidence window.

Why now: Why now is weak because the reviewed sources references article IDs, and in the membership rationale, but no or reviewed evidence are provided for ranking use.

Caveats: High mention count is not conviction. Cohort relevance via Space Force context is not enough without direct event/fact evidence. Coverage debug shows zero evidence after recent evidence window despite large article universe.